IRTC Q2 2024 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$148M+19.3% YoY

Gross Profit

$103M69.9% margin

Operating Income

-$23M-15.5% margin

Net Income

-$20M-13.6% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

+12.2%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$3M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$919M

Total Liabilities

$820M

Stockholders' Equity

$99M

Cash & Equivalents

$551M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$148M	$124M	+19.3%
Gross Profit	$103M	$86M	+20.0%
Operating Income	-$23M	-$19M	-21.8%
Net Income	-$20M	-$18M	-8.8%

Revenue Segments

Commercial Payors

$79M54%

Centers For Medicare And Medicaid

$36M24%

Healthcare Institutions

$22M15%

Non-Contracted Third-Party Payors

$10M7%